A156100 Stock Overview
A medical company, manufactures and sells spinal implants worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
L&K Biomed Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩7,100.00 |
| 52 Week High | ₩10,400.00 |
| 52 Week Low | ₩5,930.00 |
| Beta | 1.61 |
| 1 Month Change | -3.79% |
| 3 Month Change | 3.35% |
| 1 Year Change | -12.35% |
| 3 Year Change | -24.79% |
| 5 Year Change | n/a |
| Change since IPO | -40.34% |
Recent News & Updates
L&K Biomed Ltd.'s (KOSDAQ:156100) Price Is Out Of Tune With Revenues
Dec 16
Is L&K Biomed (KOSDAQ:156100) Using Too Much Debt?
Oct 24L&K Biomed Ltd. (KOSDAQ:156100) Investors Are Less Pessimistic Than Expected
Aug 12Revenues Tell The Story For L&K Biomed Ltd. (KOSDAQ:156100)
Apr 16Recent updates
L&K Biomed Ltd.'s (KOSDAQ:156100) Price Is Out Of Tune With Revenues
Dec 16Is L&K Biomed (KOSDAQ:156100) Using Too Much Debt?
Oct 24L&K Biomed Ltd. (KOSDAQ:156100) Investors Are Less Pessimistic Than Expected
Aug 12Revenues Tell The Story For L&K Biomed Ltd. (KOSDAQ:156100)
Apr 16L&K Biomed (KOSDAQ:156100) Is Making Moderate Use Of Debt
Mar 09A Look At The Fair Value Of L&K Biomed Ltd. (KOSDAQ:156100)
Nov 24
Shareholder Returns
| A156100 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -0.3% | 2.0% | 2.6% |
| 1Y | -12.3% | 1.1% | -3.8% |
Return vs Industry: A156100 underperformed the KR Medical Equipment industry which returned 1.1% over the past year.
Return vs Market: A156100 underperformed the KR Market which returned -3.8% over the past year.
Price Volatility
| A156100 volatility | |
|---|---|
| A156100 Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A156100 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A156100's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 60 | Kang guk Jin | www.lnkbiomed.com |
L&K Biomed Ltd., a medical company, manufactures and sells spinal implants worldwide. It offers anterior and expandable lateral lumber cage systems; cervical interbody fusion cage, anterior cervical plate system, posterior cervical fixation system; spinal fixation screw, lumber plate, and spinal fixation systems, as well as posterior lumber interbody cage. The company also provides lateral and anterior lumber interbody cage, and transforaminal lumber interbody cage; MIS spinal and spinal fixation systems; and SI joint fusion system.
L&K Biomed Ltd. Fundamentals Summary
| A156100 fundamental statistics | |
|---|---|
| Market cap | ₩141.55b |
| Earnings (TTM) | -₩1.50b |
| Revenue (TTM) | ₩33.18b |
4.3x
P/S Ratio-94.4x
P/E RatioIs A156100 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A156100 income statement (TTM) | |
|---|---|
| Revenue | ₩33.18b |
| Cost of Revenue | ₩4.53b |
| Gross Profit | ₩28.66b |
| Other Expenses | ₩30.16b |
| Earnings | -₩1.50b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -75.24 |
| Gross Margin | 86.36% |
| Net Profit Margin | -4.52% |
| Debt/Equity Ratio | 64.2% |
How did A156100 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 13:25 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
L&K Biomed Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jongsun Park | Eugene Investment & Securities Co Ltd. |
| Kyung Jun Moon | MERITZ Securities Co., Ltd. |
| Jiwoo Baek | Shinhan Investment Corp. |